Abstract
Auraptene is the most abundant prenyloxycoumarin that occurs in nature. It has been isolated from plants belonging to many genus of the Rutaceae family, comprising several edible fruits and vegetables. Although known for a long time, only in the last decade auraptene was seen to exert valuable pharmacological properties as orally active cancer chemopreventive, anti-bacterial, anti-protozoal, anti-fungal, anti-inflammatory, and anti-oxidant agent. The aim of this review is to examine in detail the in so far reported effects and what is known about the mechanism of action underlying the observed pharmacological activities of this secondary metabolite by means of a survey of the current literature in which auraptene has been reported as an inhibitor of key biological targets like metalloproteinases, glycoprotein P, PPARs, and several others.
Keywords: Anti-cancer activity, anti-inflammatory activity, Citrus, cancer chemoprevention, edible plants, prenyloxycoumarins, Rutaceae
Current Drug Targets
Title: Auraptene: A Natural Biologically Active Compound with Multiple Targets
Volume: 12 Issue: 3
Author(s): Salvatore Genovese and Francesco Epifano
Affiliation:
Keywords: Anti-cancer activity, anti-inflammatory activity, Citrus, cancer chemoprevention, edible plants, prenyloxycoumarins, Rutaceae
Abstract: Auraptene is the most abundant prenyloxycoumarin that occurs in nature. It has been isolated from plants belonging to many genus of the Rutaceae family, comprising several edible fruits and vegetables. Although known for a long time, only in the last decade auraptene was seen to exert valuable pharmacological properties as orally active cancer chemopreventive, anti-bacterial, anti-protozoal, anti-fungal, anti-inflammatory, and anti-oxidant agent. The aim of this review is to examine in detail the in so far reported effects and what is known about the mechanism of action underlying the observed pharmacological activities of this secondary metabolite by means of a survey of the current literature in which auraptene has been reported as an inhibitor of key biological targets like metalloproteinases, glycoprotein P, PPARs, and several others.
Export Options
About this article
Cite this article as:
Genovese Salvatore and Epifano Francesco, Auraptene: A Natural Biologically Active Compound with Multiple Targets, Current Drug Targets 2011; 12 (3) . https://dx.doi.org/10.2174/138945011794815248
DOI https://dx.doi.org/10.2174/138945011794815248 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mineralocorticoid Receptor Antagonists in Essential and Resistant Hypertension
Current Pharmaceutical Design Patent Annotations
Recent Patents on Cardiovascular Drug Discovery High Sensitivity C-Reactive Protein (hsCRP): A New Biochemical Marker of Atherosclerotic Vascular Disease
Current Cardiology Reviews Relaxin Receptors - New Drug Targets for Multiple Disease States
Current Drug Targets Effects of Verbascoside Administration on the Blood Parameters and Oxidative Status in Jennies and Their Suckling Foals: Potential Improvement of Milk for Human Use
Endocrine, Metabolic & Immune Disorders - Drug Targets Endothelial to Mesenchymal Transition in the Cardiogenesis and Cardiovascular Diseases
Current Cardiology Reviews Immunomodulatory Properties of Farnesoids: The New Steroids?
Current Medicinal Chemistry The Long Run: Neuroprotective Effects of Physical Exercise on Adult Neurogenesis from Youth to Old Age
Current Neuropharmacology Synergistic Antitumor Effect of 5-Fluorouracil Combined with Constituents from <i>Pleurospermum lindleyanum</i> in Hepatocellular Carcinoma SMMC-7721 Cells
Anti-Cancer Agents in Medicinal Chemistry Increased Exercise Favorably Modifies Coronary Artery Disease and Peripheral Arterial Disease Outcomes
Current Vascular Pharmacology Molecular Function of Tocopherols in Age Related Diseases
Current Pharmaceutical Design Rheumatoid Arthritis: Cardiovascular Manifestations, Pathogenesis, and Therapy
Current Pharmaceutical Design The Therapeutic Potential of Rutin for Diabetes: An Update
Mini-Reviews in Medicinal Chemistry Gestational Programming of Offspring Obesity: A Potential Contributor to Alzheimers Disease
Current Alzheimer Research Natural Compounds with Cell Growth Inhibitory Activity in Human Tumor Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Vascular Effects of Ambient Pollutant Particles and Metals
Current Vascular Pharmacology ATP-Sensitive K+ Channels: Current and Putative Target for the Prevention and Treatment of Cardiovascular Diseases
Vascular Disease Prevention (Discontinued) The Role of Protease-Activated Receptors for the Development of Myocarditis: Possible Therapeutic Implications
Current Pharmaceutical Design Anti-Inflammatory Drugs in Psychiatry
Inflammation & Allergy - Drug Targets (Discontinued) MRI Abnormalities Associated with Mild Cognitive Impairments of Vascular (VMCI) Versus Neurodegenerative (NMCI) Types Prodromal for Vascular and Alzheimers Dementias
Current Alzheimer Research